VIEMED HEALTHCARE, INC.(VMD)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

VIEMED HEALTHCARE, INC. (VMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores VMD at 61.5/100 on a 32-signal composite quality model, placing it at rank #779 of 2,962 stocks — the top half of the AI-ranked universe. VMD scores in the top quartile across earnings quality (93.3), revenue growth (83.2), balance sheet strength (79.0). Areas of concern include revenue scale (29.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 30.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), VIEMED HEALTHCARE, INC. reports quarterly revenue of $78.1M, net income of $2.8M, an operating margin of 5.7%. Top institutional holders of VMD by reported 13-F value include BlackRock, Forager Capital Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. VMD trades on the Nasdaq exchange and files with the SEC under CIK 1729149. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate VMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for VIEMED HEALTHCARE, INC. directly from SEC EDGAR.